vs
Acadia Healthcare Company, Inc.（ACHC）とMAXIMUS, INC.（MMS）の財務データ比較。上の社名をクリックして会社を切り替えられます
MAXIMUS, INC.の直近四半期売上が大きい（$1.3B vs $829.0M、Acadia Healthcare Company, Inc.の約1.6倍）。MAXIMUS, INC.の純利益率が高く（7.0% vs 0.5%、差は6.4%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（7.5% vs -4.1%）。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い（2.0% vs -0.1%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
MAXIMUS社は米国の政府向けサービス企業で、米国、カナダ、英国などで事業を展開している。メディケイド、メディケア、医療改革、就労支援、学生ローン管理など各種政府プログラムに管理業務や関連サービスを提供する。本社はバージニア州タイソンズに所在し、従業員数3万9600人、2024会計年度の売上高は53億米ドルである。
ACHC vs MMS — 直接比較
損益計算書 — Q1 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $1.3B |
| 純利益 | $4.5M | $93.9M |
| 粗利率 | — | 23.7% |
| 営業利益率 | — | 10.9% |
| 純利益率 | 0.5% | 7.0% |
| 売上前年比 | 7.5% | -4.1% |
| 純利益前年比 | -50.8% | 128.0% |
| EPS（希薄化後） | $0.05 | $1.70 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.3B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.4B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.3B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $93.9M | ||
| Q3 25 | $36.2M | $75.3M | ||
| Q2 25 | $30.1M | $106.0M | ||
| Q1 25 | $8.4M | $96.6M | ||
| Q4 24 | $32.6M | $41.2M | ||
| Q3 24 | $68.1M | $72.5M | ||
| Q2 24 | $78.5M | $89.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 25.3% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 25.3% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 10.9% | ||
| Q3 25 | 4.7% | 9.3% | ||
| Q2 25 | 5.8% | 12.3% | ||
| Q1 25 | 1.7% | 11.2% | ||
| Q4 24 | 4.9% | 6.2% | ||
| Q3 24 | 12.1% | 8.5% | ||
| Q2 24 | 13.4% | 10.8% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 7.0% | ||
| Q3 25 | 4.3% | 5.7% | ||
| Q2 25 | 3.5% | 7.9% | ||
| Q1 25 | 1.1% | 7.1% | ||
| Q4 24 | 4.2% | 2.9% | ||
| Q3 24 | 8.4% | 5.5% | ||
| Q2 24 | 9.9% | 6.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.70 | ||
| Q3 25 | $0.40 | $1.27 | ||
| Q2 25 | $0.33 | $1.86 | ||
| Q1 25 | $0.09 | $1.69 | ||
| Q4 24 | $0.36 | $0.69 | ||
| Q3 24 | $0.74 | $1.18 | ||
| Q2 24 | $0.85 | $1.46 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $137.6M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $1.7B |
| 総資産 | $5.5B | $4.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $137.6M | ||
| Q3 25 | $118.7M | $222.4M | ||
| Q2 25 | $131.4M | $59.8M | ||
| Q1 25 | $91.2M | $108.1M | ||
| Q4 24 | $76.3M | $72.7M | ||
| Q3 24 | $82.1M | $183.1M | ||
| Q2 24 | $77.2M | $102.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.7B | ||
| Q3 25 | $3.1B | $1.7B | ||
| Q2 25 | $3.1B | $1.8B | ||
| Q1 25 | $3.0B | $1.7B | ||
| Q4 24 | $3.1B | $1.6B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $1.8B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $4.2B | ||
| Q3 25 | $6.4B | $4.1B | ||
| Q2 25 | $6.3B | $4.5B | ||
| Q1 25 | $6.1B | $4.2B | ||
| Q4 24 | $6.0B | $4.1B | ||
| Q3 24 | $5.9B | $4.1B | ||
| Q2 24 | $5.7B | $4.0B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | $-244.4M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $-250.7M |
| FCFマージンFCF / 売上 | — | -18.6% |
| 設備投資強度設備投資 / 売上 | — | 0.5% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | -2.60× |
| 直近12ヶ月FCF直近4四半期 | — | $218.5M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-244.4M | ||
| Q3 25 | $73.2M | $649.4M | ||
| Q2 25 | $133.5M | $-182.7M | ||
| Q1 25 | $11.5M | $42.7M | ||
| Q4 24 | $116.7M | $-80.0M | ||
| Q3 24 | $163.1M | $163.8M | ||
| Q2 24 | $171.1M | $199.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-250.7M | ||
| Q3 25 | $-63.0M | $641.8M | ||
| Q2 25 | $-34.2M | $-198.2M | ||
| Q1 25 | $-163.2M | $25.5M | ||
| Q4 24 | $-86.8M | $-103.0M | ||
| Q3 24 | $-27.1M | $131.9M | ||
| Q2 24 | $16.9M | $164.6M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -18.6% | ||
| Q3 25 | -7.4% | 48.7% | ||
| Q2 25 | -3.9% | -14.7% | ||
| Q1 25 | -21.2% | 1.9% | ||
| Q4 24 | -11.2% | -7.3% | ||
| Q3 24 | -3.3% | 10.0% | ||
| Q2 24 | 2.1% | 12.5% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.5% | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 1.3% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 2.4% | ||
| Q2 24 | 19.4% | 2.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -2.60× | ||
| Q3 25 | 2.02× | 8.63× | ||
| Q2 25 | 4.43× | -1.72× | ||
| Q1 25 | 1.37× | 0.44× | ||
| Q4 24 | 3.58× | -1.94× | ||
| Q3 24 | 2.39× | 2.26× | ||
| Q2 24 | 2.18× | 2.22× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
